These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38471352)

  • 1. Elucidation of escitalopram oxalate and related antidepressants as putative inhibitors of PTP4A3/PRL-3 protein in hepatocellular carcinoma: A multi-computational investigation.
    Mir IH; Shyam KT; Balakrishnan SS; Kumar MS; Ramesh T; Thirunavukkarasu C
    Comput Biol Chem; 2024 Jun; 110():108039. PubMed ID: 38471352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.
    Mayinuer A; Yasen M; Mogushi K; Obulhasim G; Xieraili M; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
    Ann Surg Oncol; 2013 Jan; 20(1):305-17. PubMed ID: 23064776
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Keshari AK; Singh AK; Raj V; Rai A; Trivedi P; Ghosh B; Kumar U; Rawat A; Kumar D; Saha S
    Drug Des Devel Ther; 2017; 11():1623-1642. PubMed ID: 28615927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking and dynamic simulations of
    Sangeetha R; Arockia Jeya Yasmi Prabha E; Lakshmi A; Sangavi P; Langeswaran K
    J Biomol Struct Dyn; 2022; 40(24):13997-14012. PubMed ID: 34738880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation - A systematic computational approach to discover novel cancer therapeutics.
    Chagaleti BK; B SK; G V A; Rajagopal R; Alfarhan A; Arockiaraj J; Muthu Kumaradoss K; Karthick Raja Namasivayam S
    Comput Biol Chem; 2024 Oct; 112():108134. PubMed ID: 38964206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.
    Lazo JS; Blanco IK; Tasker NR; Rastelli EJ; Burnett JC; Garrott SR; Hart DJ; McCloud RL; Hsu KL; Wipf P; Sharlow ER
    J Pharmacol Exp Ther; 2019 Dec; 371(3):652-662. PubMed ID: 31601683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from Nigella sativa L. that Inhibits P38 Protein: Probable Remedies for Hepatocellular Carcinoma.
    Tabassum H; Ahmad IZ
    Med Chem; 2020; 16(3):350-357. PubMed ID: 31038073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering best candidates for Hepatocellular Carcinoma (HCC) by in-silico techniques and tools.
    Mabrouk MS
    Int J Bioinform Res Appl; 2012; 8(1-2):141-52. PubMed ID: 22450276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9.
    Mustafa G; Younas S; Mahrosh HS; Albeshr MF; Bhat EA
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Insights into Chromene/pyran Derivatives: Molecular Docking, ADMET Studies, DFT Calculations, and MD Simulations as Promising Candidates for Parkinson's Disease.
    Rani A; Aslam M; Khan J; Pandey G; Singh P; Maharia RS; Nand B
    Chem Biodivers; 2024 Aug; 21(8):e202400920. PubMed ID: 38818615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
    Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational assessment of chemicals from
    Ugwah-Oguejiofor CJ; Chukwuka EP; Onifade OF; Agu ST; Adegboyega AE; Johnson GI; Ogunsuyi OI; Johnson TO
    J Biomol Struct Dyn; 2023; 41(22):13271-13286. PubMed ID: 36709454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the Biological Activity of Trans-[Cu (quin)2(EtOH)2] as Potent Antimicrobial Cu(II) Complex through Computational Investigations: DFT, ADMET and Molecular Docking.
    Hussein RK; El-Khayatt AM; Duaij OKA; Alkaoud AM
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):84. PubMed ID: 37114549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing of Strychnine as the Potential Inhibitors of Aldo-keto Reductase Family 1 Members B1 and B10: Computational Modeling and Pharmacokinetic Analysis.
    Sarfraz M; Aziz M; Afzal S; Channar PA; Alsfouk BA; Kandhro GA; Hassan S; Sultan A; Hamad A; Arafat M; Qaiser MN; Ahmed A; Siddique F; Ejaz SA
    Protein J; 2024 Apr; 43(2):207-224. PubMed ID: 37940790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational drug design for identifying novel multi-target inhibitors for hepatocellular carcinoma.
    Temirak A; Abdulla M; Elhefnawi M
    Anticancer Agents Med Chem; 2012 Nov; 12(9):1088-97. PubMed ID: 22583422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DFT, ADMET and Molecular Docking Investigations for the Antimicrobial Activity of 6,6'-Diamino-1,1',3,3'-tetramethyl-5,5'-(4-chlorobenzylidene)bis[pyrimidine-2,4(1H,3H)-dione].
    El-Shamy NT; Alkaoud AM; Hussein RK; Ibrahim MA; Alhamzani AG; Abou-Krisha MM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.